NCT00973804 2019-12-17Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood DisordersNational Institutes of Health Clinical Center (CC)Phase 1 Terminated4 enrolled